ERBB2 and invasive breast carcinoma: By analyzing selected tumor types, as invasive breast cancer, colorectal adenocarcinoma and skin cutaneous melanoma, we observed that both ERBB2 and NCR3LG1 transcripts show a variable, heterogeneous and non-correlative expression for each individual patient (Figure 1(b)).